Trial · NCT00391222
Participant flow24
How many started, completed or left each group, period by period.
1 to 20 of 24
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Period II (Open-label Risperidone LAI) | STARTED | Risperidone LAI | 0 | |
| Period II (Open-label Risperidone LAI) | STARTED | Placebo | 0 | |
| Period II (Open-label Risperidone LAI) | STARTED | Olanzapine | 0 | |
| Period II (Open-label Risperidone LAI) | STARTED | Open-label Risperidone LAI | 560 | |
| Period II (Open-label Risperidone LAI) | COMPLETED | Risperidone LAI | 0 | |
| Period II (Open-label Risperidone LAI) | COMPLETED | Placebo | 0 | |
| Period II (Open-label Risperidone LAI) | COMPLETED | Olanzapine | 0 | |
| Period II (Open-label Risperidone LAI) | COMPLETED | Open-label Risperidone LAI | 398 | |
| Period II (Open-label Risperidone LAI) | NOT COMPLETED | Risperidone LAI | 0 | |
| Period II (Open-label Risperidone LAI) | NOT COMPLETED | Placebo | 0 | |
| Period II (Open-label Risperidone LAI) | NOT COMPLETED | Olanzapine | 0 | |
| Period II (Open-label Risperidone LAI) | NOT COMPLETED | Open-label Risperidone LAI | 162 | |
| Period III (Double-Blind Treatment) | STARTED | Risperidone LAI | 132 | |
| Period III (Double-Blind Treatment) | STARTED | Placebo | 135 | |
| Period III (Double-Blind Treatment) | STARTED | Olanzapine | 131 | |
| Period III (Double-Blind Treatment) | STARTED | Open-label Risperidone LAI | 0 | |
| Period III (Double-Blind Treatment) | COMPLETED | Risperidone LAI | 104 | |
| Period III (Double-Blind Treatment) | COMPLETED | Placebo | 113 | |
| Period III (Double-Blind Treatment) | COMPLETED | Olanzapine | 108 | |
| Period III (Double-Blind Treatment) | COMPLETED | Open-label Risperidone LAI | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00391222/flow